NCT00299806View on ClinicalTrials.gov

SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Japan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY